BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 11889419)

  • 21. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-17-dependent cellular immunity to collagen type V predisposes to obliterative bronchiolitis in human lung transplants.
    Burlingham WJ; Love RB; Jankowska-Gan E; Haynes LD; Xu Q; Bobadilla JL; Meyer KC; Hayney MS; Braun RK; Greenspan DS; Gopalakrishnan B; Cai J; Brand DD; Yoshida S; Cummings OW; Wilkes DS
    J Clin Invest; 2007 Nov; 117(11):3498-506. PubMed ID: 17965778
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of allosensitization in allograft recipients: long-term cardiac allograft acceptance is associated with active alloantibody production in conjunction with active inhibition of alloreactive delayed-type hypersensitivity.
    VanBuskirk AM; Wakely ME; Sirak JH; Orosz CG
    Transplantation; 1998 Apr; 65(8):1115-23. PubMed ID: 9583874
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alloreactive delayed-type hypersensitivity in graft recipients: complexity of responses and divergence from acute rejection.
    Sirak J; Orosz CG; Wakely E; VanBuskirk AM
    Transplantation; 1997 May; 63(9):1300-7. PubMed ID: 9158025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bronchiolar basement membrane changes associated with bronchiolitis obliterans in lung allografts: a retrospective study of serial transbronchial biopsies with immunohistochemistry [corrected].
    Siddiqui MT; Garrity ER; Martinez R; Husain AN
    Mod Pathol; 1996 Mar; 9(3):320-8. PubMed ID: 8685235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alcohol ingestion by donors amplifies experimental airway disease after heterotopic transplantation.
    Mitchell PO; Guidot DM
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1161-8. PubMed ID: 17717204
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lung transplantation in the Fischer 344-->Wistar Kyoto rat strain combination is not suitable to study bronchiolitis obliterans.
    Hirschburger M; Greschus S; Kuchenbuch T; Plötz C; Obert M; Traupe H; Padberg W; Grau V
    J Heart Lung Transplant; 2007 Apr; 26(4):390-8. PubMed ID: 17403482
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reflux-induced collagen type v sensitization: potential mediator of bronchiolitis obliterans syndrome.
    Bobadilla JL; Jankowska-Gan E; Xu Q; Haynes LD; Munoz del Rio A; Meyer K; Greenspan DS; De Oliveira N; Burlingham WJ; Maloney JD
    Chest; 2010 Aug; 138(2):363-70. PubMed ID: 20418369
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung transplantation: chronic allograft dysfunction and establishing immune tolerance.
    Gracon AS; Wilkes DS
    Hum Immunol; 2014 Aug; 75(8):887-94. PubMed ID: 24979671
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preservation of donor cornea prevents corneal allograft rejection by inhibiting induction of alloimmunity.
    Kamiya K; Hori J; Kagaya F; Usui T; Amano S; Oshika T; Mizouchi T; Tsuru T; Yamagami S
    Exp Eye Res; 2000 Jun; 70(6):737-43. PubMed ID: 10843778
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synergism of imatinib, vatalanib and everolimus in the prevention of chronic lung allograft rejection after lung transplantation (LTx) in rats.
    Keil L; Schaub AL; Hirt SW; Schmid C; Lehle K; von Suesskind-Schwendi M
    Histol Histopathol; 2019 Jul; 34(7):821-834. PubMed ID: 30706940
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LTB4 and montelukast in transplantation-related bronchiolitis obliterans in rats.
    Tu ZL; Zhou ZY; Xu HC; Cao JL; Ye P; Wang LM; Lv W; Hu J
    J Cardiothorac Surg; 2017 May; 12(1):43. PubMed ID: 28545478
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dependence of acquired systemic tolerance to rat islet allografts induced by intrathymic soluble alloantigens on host responsiveness, MHC differences, and transient immunosuppression in the high responder recipient.
    Fiedor P; Jin MX; Hardy MA; Oluwole SF
    Transplantation; 1997 Jan; 63(2):279-83. PubMed ID: 9020331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergism of imatinib mesylate and everolimus in attenuation of bronchiolitis obliterans after rat LTX.
    von Suesskind-Schwendi M; Valenti V; Haneya A; Pühler T; Bewig B; Schmid C; Hirt SW; Lehle K
    Histol Histopathol; 2013 Oct; 28(10):1273-84. PubMed ID: 23471704
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Permanent acceptance of liver allografts by intraportal injection of donor spleen cells in rats.
    Nakano Y; Monden M; Valdivia LA; Gotoh M; Tono T; Mori T
    Surgery; 1992 Jun; 111(6):668-76. PubMed ID: 1595063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of obliterative bronchiolitis after allogeneic rat lung transplantation: implication of acute rejection and the time point of treatment.
    Hirt SW; You XM; Möller F; Boeke K; Starke M; Spranger U; Wottge HU
    J Heart Lung Transplant; 1999 Jun; 18(6):542-8. PubMed ID: 10395352
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of anterior chamber-associated immune deviation (ACAID) on rat islet allograft rejection.
    Koevary SB; Beaudry K
    Ocul Immunol Inflamm; 2000 Mar; 8(1):39-47. PubMed ID: 10806433
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epitope analysis of the collagen type V-specific T cell response in lung transplantation reveals an HLA-DRB1*15 bias in both recipient and donor.
    Keller MR; Haynes LD; Jankowska-Gan E; Sullivan JA; Agashe VV; Burlingham SR; Burlingham WJ
    PLoS One; 2013; 8(11):e79601. PubMed ID: 24265781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of azithromycin and tanomastat on experimental bronchiolitis obliterans.
    Krenn K; Gmeiner M; Paulus P; Sela N; Torres L; Zins K; Dekan G; Aharinejad S
    J Thorac Cardiovasc Surg; 2015 Apr; 149(4):1194-202. PubMed ID: 25595376
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.